SHL Telemedicine Ltd American Depositary Shares Cash Flow Conversion Efficiency
SHL Telemedicine Ltd American Depositary Shares cash flow conversion efficiency. Based on the latest financial reports, SHL Telemedicine Ltd American Depositary Shares (SHLT) has a cash flow conversion efficiency ratio of -0.002x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-173.00K) by net assets ($70.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of SHL Telemedicine Ltd American Depositary Shares (2002–2024)
Cash flow conversion efficiency of SHL Telemedicine Ltd American Depositary Shares from 2002 to 2024. This chart illustrates how SHL Telemedicine Ltd American Depositary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SHLT live share price for real-time trading data and today's change.
SHL Telemedicine Ltd American Depositary Shares Cash Flow Conversion Ratio Explained
SHL Telemedicine Ltd American Depositary Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
SHL Telemedicine Ltd American Depositary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SHL Telemedicine Ltd American Depositary Shares ranked by their cash flow conversion efficiency. Also see SHL Telemedicine Ltd American Depositary market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SK Chemicals Co Ltd Pref
KO:28513K
|
0.000x |
|
Topmix Berhad
KLSE:0302
|
0.013x |
|
Fridenson
TA:FRDN
|
-0.054x |
|
Dierig Holding AG
XETRA:DIE
|
0.070x |
|
Wellbiotec Co. Ltd.
KO:010600
|
-0.033x |
|
Asia Plastic Recycling Holding Ltd
TW:1337
|
-0.017x |
|
Peoplein Ltd
AU:PPE
|
0.110x |
|
Jinli Group Holdings Ltd
TW:8429
|
0.001x |
Annual Cash Flow Conversion Efficiency for SHL Telemedicine Ltd American Depositary Shares (2002–2024)
The table below shows the annual cash flow conversion efficiency of SHL Telemedicine Ltd American Depositary Shares from 2002 to 2024. Review SHL Telemedicine Ltd American Depositary free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $39.25 Million | $-372.00K | -0.009x | +51.56% |
| 2023-12-31 | $76.46 Million | $-1.50 Million | -0.020x | -1489.07% |
| 2022-12-31 | $59.29 Million | $-73.00K | -0.001x | -140.44% |
| 2021-12-31 | $60.76 Million | $185.00K | 0.003x | -97.54% |
| 2020-12-31 | $37.88 Million | $4.68 Million | 0.124x | -60.42% |
| 2019-12-31 | $34.74 Million | $10.85 Million | 0.312x | -7.74% |
| 2018-12-31 | $37.68 Million | $12.76 Million | 0.338x | -16.52% |
| 2017-12-31 | $29.21 Million | $11.84 Million | 0.405x | +2351.00% |
| 2016-12-31 | $23.82 Million | $-429.00K | -0.018x | -119.28% |
| 2015-12-31 | $42.60 Million | $3.98 Million | 0.093x | +284.04% |
| 2014-12-31 | $61.40 Million | $-3.12 Million | -0.051x | -224.28% |
| 2013-12-31 | $68.91 Million | $2.81 Million | 0.041x | +53.22% |
| 2012-12-31 | $60.99 Million | $1.63 Million | 0.027x | +150.66% |
| 2011-12-31 | $66.56 Million | $-3.50 Million | -0.053x | -230.69% |
| 2010-12-31 | $74.70 Million | $3.01 Million | 0.040x | -50.01% |
| 2009-12-31 | $65.30 Million | $5.26 Million | 0.081x | +163.02% |
| 2008-12-31 | $59.07 Million | $-7.55 Million | -0.128x | -329.31% |
| 2007-12-31 | $60.50 Million | $-1.80 Million | -0.030x | -149.30% |
| 2006-12-31 | $29.81 Million | $1.80 Million | 0.060x | +1284.09% |
| 2005-12-31 | $40.78 Million | $-208.00K | -0.005x | -131.86% |
| 2004-12-31 | $81.52 Million | $1.30 Million | 0.016x | +117.32% |
| 2003-12-31 | $87.56 Million | $645.00K | 0.007x | -69.38% |
| 2002-12-31 | $92.06 Million | $2.21 Million | 0.024x | -- |
About SHL Telemedicine Ltd American Depositary Shares
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company als… Read more